Pfenex Set to Join Russell 2000® Index

SAN DIEGO, June 22, 2018 (GLOBE NEWSWIRE) — Pfenex Inc. (NYSE American:PFNX), a clinical-stage development and licensing biotechnology company focused on leveraging its Pfenex Expression Technology® to improve protein therapies for unmet patient needs, today...

Message From Urbana Corporation

NOT FOR DISTRIBUTION TO U.S. WIRE SERVICES OR FOR DISSEMINATION IN THE U.S.TORONTO, June 22, 2018 (GLOBE NEWSWIRE) — Urbana Corporation (“Urbana”) (TSX:URB) (TSX:URB.A) (CSE:URB) (CSE:URB.A)    Our Portfolio Manager, Caldwell Investment Management...